Abstract
Introduction and hypothesis Intradetrusor onabotulinumtoxinA (BTX-A) is a third-line therapy for overactive bladder (OAB), however several gaps exist ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
